CASI Pharmaceuticals, Inc.
(NASDAQ : CASI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -1.12%60.900.0%$943.14m
GILDGilead Sciences, Inc. 0.18%76.201.0%$770.14m
AMGNAmgen, Inc. 1.96%260.121.3%$763.52m
REGNRegeneron Pharmaceuticals, Inc. 1.11%615.942.5%$686.10m
NVAXNovavax, Inc. -1.79%78.27102.0%$596.05m
BIIBBiogen, Inc. 0.97%267.331.6%$548.64m
VRTXVertex Pharmaceuticals, Inc. 1.19%289.681.9%$530.40m
ILMNIllumina, Inc. 1.19%372.933.5%$312.25m
ALXNAlexion Pharmaceuticals, Inc. 0.87%113.372.0%$231.11m
BMRNBioMarin Pharmaceutical, Inc. -0.06%125.774.3%$214.61m
SGENSeattle Genetics, Inc. -0.63%166.466.1%$200.58m
SRNESorrento Therapeutics, Inc. -6.06%6.511.8%$175.60m
SRPTSarepta Therapeutics, Inc. -0.33%165.1313.9%$168.10m
INCYIncyte Corp. 2.08%104.782.5%$163.32m
IMMUImmunomedics, Inc. 0.05%36.9311.0%$154.41m

Company Profile

CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. Its products include ZEVALIN, EVOMELA and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.